Profil
Tracy Cunningham is currently the Director at Health Research Board and the Chief Medical Officer at Amryt Pharma Plc.
Previously, she worked as the Clinical Head-Oncology Research & Development at AstraZeneca PLC and as the Vice President & Head-Development at Amryt Pharma Holdings Ltd. Dr. Cunningham completed her undergraduate degree at the Royal College of Surgeons.
Aktiva positioner av Tracy Cunningham
| Företag | Position | Start |
|---|---|---|
| AMRYT PHARMA PLC | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Tracy Cunningham
| Företag | Position | Slut |
|---|---|---|
| ASTRAZENECA PLC | Företagsledare/Principal | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Teknisk/Vetenskaplig/F&U Direktör | - |
Tracy Cunninghams utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Government |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
















